Validation of the French Version of the Edinburgh Postnatal Depression Scale (EPDS) Postnatally in the Father
EPDS-PERE
1 other identifier
interventional
1,000
1 country
2
Brief Summary
In recent years, fatherhood has changed considerably. Fathers are now more involved during the perinatal period, with their partner but also in caring for the child. Investigators now know that this period is also a source of major psychological upheaval, identity crisis, apprehension and anxiety for men. These upheavals can lead to depression that must be detected and treated as early as possible. This is an easy screening to perform using the EPDS (Edinburgh Postnatal Depression Scale). Currently, the EPDS is the most widely used self-questionnaire to assess the risk of depression in women during the perinatal period. Indeed, it is systematically recommended in many countries. It is starting to be used for the same purpose in the perinatal period in men, although the scale has not been validated in a representative sample of men in the pre- or post-natal period. The main objective is to validate the use of the EPDS scale as a screening tool for postnatal depression in a population of French fathers. They complete the PH-Q9, EPDS and socio-demographic questionnaires online at inclusion and 6 to 8 weeks after the birth of their child. Fathers included at the maternity ward also too Mini International Neuropsychiatric Interview (MINI) at inclusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 11, 2024
CompletedFirst Submitted
Initial submission to the registry
January 9, 2025
CompletedFirst Posted
Study publicly available on registry
January 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 12, 2027
January 21, 2026
January 1, 2026
2.5 years
January 9, 2025
January 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Mini International Neuropsychiatric Interview
This short structured clinical interview is used to diagnose psychiatric disorders and is currently the gold standard for diagnosing depression.
at inclusion
Secondary Outcomes (1)
socio-demographic questionnaire
at inclusion and 6 to 8 weeks after the birth of their child
Study Arms (2)
Fathers included at the maternity hospital or through their wife
ACTIVE COMPARATORAt inclusion, fathers included at the maternity hospital or through their wife take the Mini International Neuropsychiatric Interview and complete the EPDS book (PH-Q9, EPDS and socio-demographic questionnaire). 6 to 8 weeks after the birth of their child, they complete only EPDS book.
fathers includes through the awareness campaign
EXPERIMENTALAt inclusion, fathers included through the awareness campaign have only the EPDS book (PH-Q9, EPDS and socio-demographic questionnaire) at inclusion. 6 to 8 weeks after the birth of their child, they complete the same EPDS book.
Interventions
Fathers have Mini International Neuropsychiatric Interview, the standard diagnostic tool for post-natal depression
PH-Q9, EPDS and socio-demographic questionnaires are completed online at inclusion and 6 to 8 weeks after the birth of child.
Eligibility Criteria
You may qualify if:
- All fathers whose baby is 10 days old or less
You may not qualify if:
- People with a poor understanding of spoken or written French
- Minors
- Persons under court protection, guardianship or curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Antoine-Béclère hospital AP-HP
Clamart, 92140, France
Le Havre hospital - site Jacques Monod
Montivilliers, 76290, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2025
First Posted
January 13, 2025
Study Start
July 11, 2024
Primary Completion (Estimated)
January 12, 2027
Study Completion (Estimated)
March 12, 2027
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share